Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathways
Rehab F. Abdel‐Rahman(National Research Centre), Hanan A. Ogaly(Cairo University), Alyaa F. Hessin(National Research Centre), Mahmoud S. Arbid(National Research Centre), Marawan A. Elbaset(National Research Centre), Hany M. Fayed(Institute of Clinical Research), Abeer Salama(National Research Centre), Sahar S. Abdelrahman(Cairo University), Gihan F. Asaad(National Research Centre)
Cited by 24
Related Papers
Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives
|Biomedicine & Pharmacotherapy|2023|139
The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats
|PLoS ONE|2021|48
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats
|Chemico-Biological Interactions|2018|47